WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.

Stein-Gold, Linda; Kircik, Leon H; Draelos, Zoe Diane; Werschler, Philip; DuBois, Janet; Lain, Edward; Baumann, Leslie; Goldberg, David J et al. · J Am Acad Dermatol · 2018

Where this comes from

Record sourced from PubMed, PMID 29409915.
Also identified by DOI 10.1016/j.jaad.2018.01.028.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Read the full text

View on PubMed · Publisher (DOI)